NCT04575844View on ClinicalTrials.gov

Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Metabolic Syndrome
Interventions
DRUG

Liraglutide

24 weeks of Liraglutide

OTHER

Exercise training

24 weeks of Exercise training

DRUG

Liraglutide + Exercise training

24 weeks of Liraglutide + Exercise training

Trial Locations (1)

22906

RECRUITING

University of Virginia, Charlottesville

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Virginia

OTHER